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Using Dashboard Networks to Visualize Multiple
Patient Histories: A Design Study on
Post-operative Prostate Cancer
Ju¨rgen Bernard, Member, IEEE, David Sessler, Jo¨rn Kohlhammer, Member, IEEE, and Roy A. Ruddle
Abstract—In this design study, we present a visualization technique that segments patients’ histories instead of treating them as raw
event sequences, aggregates the segments using criteria such as the whole history or treatment combinations, and then visualizes the
aggregated segments as static dashboards that are arranged in a dashboard network to show longitudinal changes. The static
dashboards were developed in nine iterations, to show 15 important attributes from the patients’ histories. The final design was
evaluated with five non-experts, five visualization experts and four medical experts, who successfully used it to gain an overview of a
2,000 patient dataset, and to make observations about longitudinal changes and differences between two cohorts. The research
represents a step-change in the detail of large-scale data that may be successfully visualized using dashboards, and provides
guidance about how the approach may be generalized.
Index Terms—Information Visualization, Visual Analytics, Multivariate Data Visualization, Electronic Health Care Records, Medical
Data Analysis, Prostate Cancer Disease, Design Study, User Study, Evaluation, Static Dashboard, Dashboard Network.
F
1 INTRODUCTION
V ISUALIZATION has the potential to become an integral partof medical health care. For that, the visualization of patient
histories from electronic health record data is one of the central
subjects of interest, and can support medical research, clinical
treatment, and communication between medical experts (physi-
cians) and patients [1]. However, real-world patient histories often
provide a wealth of information about multiple attributes about
patients, e.g., outcome variables and treatment conditions [2]. It
follows that a large amount of data is sometimes needed to reason
about the well-being and treatment decisions of patients, making
the visualization of detailed patient histories a challenging task.
Two current approaches are as follows. The visualization of
single patient histories has been applied in various applications
[3], supporting tasks for different stakeholders [4]. Visualization
techniques can show multiple attributes of specific patients in
a single diagram. However, the emphasis on details means that
these visualizations do not scale well, which makes it tedious to
compare multiple patients. To address this, a second visualization
approach aims to let users see the event sequences of multiple
patients at a glance. The strategy of this approach is to abstract
complex histories into different event categories or discrete states
[5]. Thus, every patient history is represented as a sequence
of symbols, which can be visually aggregated to show multiple
patients. However, given the fact that every patient has a unique
history, this approach involves the loss of a lot of potentially
valuable information.
Showing both multiple patients and multiple patient attributes
at the same time remains a research challenge. If suitable visual-
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ization techniques could be developed then users would be able to
gain an overview of large sets of patient histories and discover
details about specific patient attributes. Interesting relations in
the data could be identified, e.g., that many patients sharing
specific properties in a pathology report will develop similarly in
their follow-up. In addition, such visualizations would allow the
comparison of different patient cohorts, which would help medical
experts to assess specific causes and outcomes.
The present paper describes the design and evaluation of a
technique for visualizing patient histories, using post-operative
prostate cancer as an example. Overall this paper makes three
primary contributions. First, we show that by segmenting pa-
tients’ histories, instead of treating them as raw event sequences,
segments can be aggregated using a variety of criteria (e.g.,
whole history vs. treatment combinations) and visualized as a
compact static dashboard that depicts a broad range of treatments
and outcome variables. Second, we demonstrate that the static
dashboards may be arranged as dashboard networks that allow
users to make a wide variety of observations about longitudinal
and cross-cohort changes in patients’ histories. Third, we show
that our visualization technique is effective for users who range
from medical experts and visualization experts to people who are
not expert in either field.
The following sections describe the background of the re-
search, the iterative design process, and then a user evaluation.
The evaluation was conducted with three groups of users: non-
experts, visualization experts, and medical experts.
2 RELATED WORK
We structure the related work by the class of visualization tech-
niques that was applied, which in many cases depends on the
analytical task to be supported. Overall, we follow the distinction
proposed by Rind et al. [3] where 14 visualization systems for
electronic health records were compared for clinical research or
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practice. First, we review approaches where single patient histories
were visualized with an emphasis on techniques including multi-
ple patient attributes. Second, we discuss systems that gave an
overview of multiple sequences, which typically were represented
as a set of event types or visual symbols. Extending the survey of
Rind et al., we summarize visualization techniques for multivariate
data with an emphasis on medical data visualization.
2.1 Visualization of Single Patient Histories
Some early techniques for displaying graphical summaries of
status of patients were presented by Powsner and Tufte [6], [7]
over 20 years ago. That research was complemented by LifeLines
[8], which was an interactive tool for visualizing patient histories
and used a variety of visual encodings to show longitudinal health
record data.
Other tools have been developed more recently. One used the
color semantics of a traffic light to indicate patient well-being over
time [9]. Bernard et al. [10] also used a traffic light color scheme
to combine the progression of the PSA hormone value with
multiple clinical and histological dimensions in a tool that allowed
users to interactively define cohorts. In a follow-up approach,
the authors optimized the visualization of patient histories for an
active learning approach for the assessment of patient well-being
[11]. Although, these tools allow the visualization of multivariate
information about single patients over time, the visualization of
multiple patient histories in a compact way, be it juxtaposed or
superimposed [12], remains the subject of current research.
2.2 Visualization of Event Sequences of Patients
To visualize the histories of multiple patients, the data is often sim-
plified by either abstracting events to a set of states or aggregating
identical events and sequences into higher-level sequences. All of
these approaches increase visual scalability, and example tools are
LifeLines2 [13], Outflow [14], CareFlow [15], DecisionFlow [16],
LifeFlow [17], and EventFlow [18], [19].
A core analysis task in LifeLines2 [13] is the visualization
and temporal comparison of multiple records that have been
abstracted to event sequences. We take up this idea and apply
it to multivariate states of multiple patents using a suite of charts
for different patient attributes. Similarly, the LifeFlow approach
[17] converts histories to a tree-based data structure that is used
for the visualization of simplified sequences. While we also
apply aggregation, our visualizations combine different graphics
techniques for the visual aggregation of patient states.
EventFlow [19] allows users to adopt filtering and substitution
strategies to simplify data. StratomeX enables the interactive
editing of patient groups and provides visual feedback for rela-
tions across different data sources [20]. Similarly, TimeSpan [21]
visualizes temporal event-sequence data and multi-dimensional
data for individual patients. It provides matrix representations and
reordering techniques for exploring patterns and new hypotheses
in data. COQUITO [22] uses networks with abstracted temporal
information to show patient cohorts as the result of interactive
temporal queries. CoCo [23] applies visual analytics and statistical
testing for the visual comparison of cohorts, based on an abstrac-
tion of patient histories to event sequences. EventAction [24] also
builds upon statistical testing, while emphasizing the combination
of summaries of attributes and event sequences. As such, CoCo
and EventAction are examples which can be combined with the
static dashboard networks presented in this work to facilitate the
visual comparison of differentiating attribute values.
To extend the functionality of approaches based on event
sequence visualization, we want to visualize multiple patient at-
tributes. The combination of being able to visualize both multiple
event sequences and multiple attributes of patients is central to the
requirements of medical experts and the motivating challenge for
the visualization design of the present research.
2.3 Visualization of Multivariate Attribute Sets
Our visualization design relies on design principles for the vi-
sualization of multivariate data. According to the medical ex-
perts (prostate cancer clinicians) with whom we collaborated,
15 attributes provide information that is important in prostate
cancer health care. Those attributes are of a variety of data types
(numerical, ordinal, categorical, and binary), which is why vi-
sualization techniques that were designed for numerical attributes
(e.g., parallel coordinates [25], RadViz [26], pixel displays [27], or
scatterplot matrices [28]) are not appropriate. Therefore, we base
our static dashboard on a class of techniques for the visualization
of multivariate data with different attribute types (mixed data),
using assemblies of small visual objects (charts) to represent
individual attributes. For related reviews, we refer readers to the
works of Fuchs [29], Borgo et al. [30], and Loorak et al. [31].
The design of intuitive and useful static dashboards for mul-
tiple attributes is a non-trivial endeavor, because designers have
to consider the characteristics of the data, the intended analytical
tasks, and the requirements and preferences of users (e.g., seman-
tics). In addition, designers must be aware of perceptual principles
of visual variables, gestalt psychology, and semiology [32], [33],
[34], [35]. If designed appropriately then such visualizations show
complex data and relationships in a compact and intuitive way,
and some examples from the bio-medical domain are as follows.
Similar to our approach, Maguire et al. present a visualization
describing progress over time [36] to visualize workflows of
biological experiments. Horn et al. present a so-called structured
metaphor graphic object for the identification of multiple parame-
ters in the context of intensive care units [37]. We build upon that
idea to assemble multiple attributes in a compact and structured
way. Other techniques visualize human body configurations, al-
lowing the analysis motion over time, e.g., to assess health recov-
ery. Along these lines, the FuryExplorer approach [38] uses a stick
figure metaphor for the assessment of health recovery. Similar
to our static dashboard, the visualizations can represent multiple
objects, conveying a notion of the variance. An alternative idea is
the use of natural objects to encode abstract data. With DICON,
Cao et al. [39] present visualizations representing distributions of
multivariate data, emphasizing cluster exploration as an important
analysis task.
In summary, some of the above approaches focus on the
visualization of single patients, while others visualize multiple
event sequences in a more abstracted way. These two general
choices either allow the visualization of dozens of attributes for
few patient histories, or the visualization of a few attributes for
hundreds or thousands of patient histories. However, the challenge
of visualizing multiple attributes for many patient histories re-
mains unsolved. For this, we consider that an assembly of carefully
designed visual objects is well-suited.
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3 APPLICATION BACKGROUND
The present research combines a design study methodology [40],
[41] with the application area of post-operative prostate cancer
to develop methods for visualizing multi-attribute patient histo-
ries. We have been collaborating with four medical experts at
the Department of Prostate Cancer at the Universita¨tsklinikum
Hamburg-Eppendorf (UKE), who take care of several thousand
patients per year and perform over 2,000 surgical procedures per
year. This collaboration involved bi-monthly meetings with two of
the medical experts, and two additional medical experts who gave
feedback during the design study. The following sections introduce
prostate cancer treatment, describe requirements for visualizations
of multi-attribute patient histories, and characterize the real-world
dataset that we used to design and evaluate the visualizations.
3.1 Treatment of Post-Operative Prostate Cancer
Prostate cancer is a disease that affects millions of men all over
the world. Clinics gather diverse information about patients in
the form of electronic health records, including demographic
data, blood and histological samples, clinical data and surveys
of follow-up care. One of the medical experts’ primary goals is
to improve the accuracy of early prognoses, e.g., by analyzing
diagnostic information. For this, much effort is spent on the
stratification of patients into cohorts to allow cohort histories to be
compared, so that medical experts can improve treatment quality
and avoid treatments that are harmful or unnecessary.
One of the diagnostic indicators (see Table 1) is the progres-
sion of the PSA hormone (a prostate-specific antigene enzyme).
Another important biological indicator is the occurrence of metas-
tases, which implies a bad prognosis for a patient and typically
occurs in late stages of the disease. Additional information about
the type of carcinoma can be gained from histopathology variables
that are assessed by the pathologist post-operatively and only once:
the Gleason score, information about affected lymph nodes (pN-
status) and the tumor class (pT-status). Four of the most common
treatments are surgery (OP), radiation therapy (RTX), hormone
therapy (HT), and chemotherapy (CHT). These treatments have
local (OP, RTX) or global (HT, CHT) implications on the human
body. Additional outcome variables are gathered to quantify treat-
ment success. The relapse of patients after surgery (biochemical
recurrence, BCR) is one such an indicator, which is often assessed
with the PSA progression, and another is information about death
(death of disease; DOD).
3.2 Requirements
UKE currently uses two visualization methods. The first is paper
print outs of single “patient plots” with multiple attributes, to iden-
tify and discuss differences between specific patients. The second
is a visual analytics tool that allows medical experts to stratify
patient cohorts and correlate cohorts with static attributes [10].
However, several other functionalities remain unsupported. These
can be structured into the following three groups of requirements:
1) Giving overviews: Providing an overview of a group of
patients for strategic planning with hospital managers or for
communicating potential treatment outcomes during patient
consultation.
2) Presenting longitudinal changes: Patterns of disease progres-
sion and treatment outcomes for use in clinical team meetings
or for showing temporal patterns in patient histories.
3) Comparing cohorts: Complementing statistical findings with
visualizations that summarize cross-cohort patterns of patient
histories in the medical experts’ scientific papers.
The complexity of diseases such as prostate cancer means
that, to be useful, visualizations need to be capable of presenting
multiple attributes of patient histories. For some use cases it is
sufficient to present a segment of a set of histories (e.g., for giving
an overview), others benefit from showing changes as a disease
progresses, and the remainder will typically involve both disease
progression and an understanding of differences between patient
cohorts (as in the third group above). The audience for the visu-
alizations ranges from people with little knowledge of a specific
disease over medical experts to clinical teams that are comprised
of different user groups (e.g., clinicians and nursing staff).
3.3 Data Characterization and Abstraction
This section describes the data and its abstraction. We provide
details about the data collection as well as the characteristics
of patient histories and patient attributes in Section 3.3.1. Next,
we present information about data processing, i.e., how we went
from patient histories to the data used in dashboard networks.
The two core steps in this process are the segmentation of patient
histories (Section 3.3.2) and the downstream aggregation of patient
segments (Section 3.3.3).
3.3.1 Patient Histories and Attributes
We had access to a pseudonymized portion of the data that
contained the histories of patients who had had surgery (OP).
In addition, all of the patients in this dataset had a relapse after
surgery (BCR) and received a second type of treatment. The
medical experts call such a collection of patients a ‘negative-
selection’, though a relapse is fortunately not common.
The data collection contained almost 2,000 histories, which
is one of the largest collections for prostate cancer patients in
Europe. The dataset is important to the medical experts for both
research and practice, because the dataset underpins data-driven
research and is increasingly used to provide scientific evidence for
medical hypotheses. During hypothesis generation and validation,
one fundamental analysis task is the identification and commu-
nication of specific properties of individual patient cohorts. Our
visualization design and user evaluation is targeted towards the
visual comparison of histories of different patient cohorts, and
thus match that task.
For medical experts, the choice of attributes, their abstrac-
tion, and visual representation has a significant influence on the
usefulness of a visualization for a given analytical task. Based
on our previous discussions with UKE experts, we selected 15
attributes describing the conditions from both the biological and
the treatment perspective. In this way, we preserved the details
of individual patients which can be highly specific since every
patient history is unique. Four of the outcome variables reflect
the histology report that was gathered after surgery (pT-status,
pN-status, as well as two histological Gleason scores). Patients
in the dataset had up to four different treatments, leading to four
treatment attributes (surgery, radiation therapy, hormone therapy,
and chemotherapy). Moreover we include four outcome variables
occurring in the course of the post-surgery observation (OK after
surgery, relapse, metastases, death of disease). The four remaining
attributes describe the progression of the PSA hormone (pre-
OP PSA, PSA at segment start, PSA at segment end, PSA
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Attribute Description Att. Type Value Domain Visual
Enc.
PSA Pre-OP The value of the PSA hormone is a most important biological indicator for
prostate cancer. Last measurement of the PSA hormone before OP (surgery).
Numerical [0;200.0[ ng
ml
median : 8.7
PSA at segment
start
Value of the PSA hormone at start of the visualized temporal segment. Numerical [0;4,472.0[ ng
ml
median : 0.21
PSA at segment
end
Value of the PSA hormone at the end of the visualized temporal segment. Used
to assess the progression of the PSA value within the segment interval.
Numerical [0;4,472.0[ ng
ml
median : 0.26
PSA trend in
segment
Trend of the PSA hormone value within the duration of a temporal segment.
Depicts the delta between the PSA values in a relative way.
Numerical ]−70.3;4381.68[ ng
ml
median : 0.0
pT-status Histopathological status of the tumor, obtained by pathology report (pT -
pathological tumor). Used for prognoses about the progress of the disease.
Ordinal pt2a, pt2b, pt2c, pt3a
pt2b, pt3c, pt4
pN-status Histopathological characteristics of the tumor, obtained by pathology report.
Used for prognoses about the progress of the disease.
Ordinal NX ,N0,N1
Gleason Score Histopathological characteristics of the tumor, obtained by pathology report.
Used for prognoses about the progress of the disease.
Ordinal 2+3, 3+2, 3+3, 3+4, 3+5,
4+3, 4+4, 4+5, 5+3, 5+4
OK after OP Outcome variable (biological condition) reflecting a good condition after OP.
Is active until relapse or metastases.
Boolean [ f alse, true]
BCR Outcome variable (biological condition) describing the biochemical recurrence
(relapse) of the tumor. Used for prognoses about the progress of the disease.
Boolean [ f alse, true]
Metastases Outcome variable (biological condition) describing whether a patient got
metastases. Metastases are the most severe biological indicator in the dataset.
Boolean [ f alse, true]
DOD Biological end point when a patient died of disease. Often used for cause-effect
analyses.
Boolean [ f alse, true]
OP Treatment attribute reflecting whether a patient had surgery. In the dataset all
patents received OP.
Boolean [ f alse, true]
RTX Treatment attribute reflecting whether a patient got radiation therapy. Local
treatment, only affecting the prostate area.
Boolean [ f alse, true]
HT Treatment attribute reflecting whether a patient had hormone therapy. Systemic
treatment, affecting the whole human body.
Boolean [ f alse, true]
CHT Treatment attribute reflecting whether a patient got chemotherapy. Often
applied in severe situations, e.g., when metastases are detected.
Boolean [ f alse, true]
TABLE 1
Overview of 15 most relevant attributes describing the condition of a patient. We provide individual visual encodings for each attribute. All
encodings comply with the requirement of showing information either of single patients or of groups of patients (clusters). When a group of
patients is visualized the dimensionality to be depicted increases from 16 (Gleason is 2D) to 19 (encoding of variation). For boolean attributes,
such as OP, the pie represents a ratio patients having a distinct attribute. Gleason Score is special as it has two independent integer dimensions.
trend). Table 1 provides an overview of the 15 attributes, their
characteristics, and their visual encodings.
3.3.2 Segmentation of Patient Histories
In this work, we refer to segmentation as the division of complex
temporal data into meaningful time-ordered parts [42]. Tempo-
ral segments of multivariate data allow data visualization and
analysis in finer granularity. The visualization of individual seg-
ments within patient histories is directly supported by the static
dashboard visualization technique. The segmentation routine that
was used in the present research is the result of a design study
that we conducted with medical experts [11]. At the experts’
recommendation, each segment of a patient history keeps most
information constant so that each new segment signifies a state
change in the history.
The segmentation routine worked by traversing a patient’s
history with a given step size and a maximum window length (one
week and six months, respectively, in our case), using a sliding
window approach. A new segment was created if at least one of
the following two criteria was met. First, the PSA value changed,
a new treatment occurred (OP, RTX, HT, or CHT), or a new
outcome occurred (OK, BCR, Metastases, or DOD; see Table 1).
As a result, every change in a patient history triggers the routine
to create a new segment. Please note that the three remaining
attributes pT-status, pN-status, and Gleason always change with
OP (histology report). With the first criterion the length of a
segment depends on the aggressiveness of the patient’s tumors,
but is typically a few months. However, in situations where a
patient has a severe condition, there may be rapid changes in the
history so each temporal segment covers a shorter period of time.
The second segmentation criterion is activated when the traversed
segment reaches the maximum length without attribute changes.
This criterion allows slower disease progression to be segmented,
by creating multiple states for a constant state. A state change in
the numerical value of the PSA hormone leads to different values at
the segment start and segment end, which indicates the PSA trend.
Overall, the routine created 10,485 segments for the 2,000 pa-
tients. Typically, a patient history yielded three to seven segments.
3.3.3 Aggregation of Segments
We use the term aggregation to refer to the process by which
segments were grouped for display in a given static dashboard. The
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medical experts proposed several possible aggregation criteria,
including the number of treatments, patient outcomes and the
value of the PSA hormone, and other criteria could also be applied
(see Section 6.4). In the present paper, two criteria are illustrated
and were used in the user evaluation (see Section 6). The first
was simply to aggregate all 10,485 segments together, to provide
an overview of all of the patient histories in one static dashboard
(Figure 1). The second was to divide patients into cohorts, and then
aggregate each cohort’s segments according to the combination of
treatments (OP, RTX, HT, or CHT) that had been provided. When
the resulting static dashboards were assembled into a dashboard
network, the number of treatments increases from left to right, and
different treatment combinations cause a network to branch (see
Figures 3 and 4 for the pt4 and pt2c cohorts, respectively).
Once segments have been created (see Section 3.3.2), the ag-
gregated data to be displayed in each static dashboard is calculated
using the following two steps. In the first step, the aggregation
routine creates a number of bins, with the specification of bins
depending on the aggregation criterion that was chosen. In the
second step, segments are assigned to appropriate bins.
The criterion for Figure 1 is that there is a single bin for all
segments, whereas in Figures 3 and 4 the aggregation routine
creates a bin for every treatment combination. In general, if the
criterion is based on a categorical attribute, we recommend that
categorical attributes are binned so that the most frequent cate-
gories are assigned to individual bins, and remaining categories
are grouped together [43]. For numerical attributes (e.g., PSA), the
bins are defined according to standard binning variants which can
be domain-preserving (the default in the present paper), frequency-
preserving, or be based on a goodness-of-fit measure [44], [45].
4 VISUALIZATION DESIGN
This section describes the design of the dashboard networks,
which we developed to visualize multiple attributes in patient
histories. The overall challenge was to create a design that allowed
users to gain an overview of a set of patient histories (e.g., Figure
1), assess changes that took place over time in a given cohort (e.g.,
Figure 3), and compare two cohorts (e.g., Figure 3 vs. Figure 4).
The following sections describe the design concept, the iterative
design process, and four key aspects of the design: the use of color,
visual aggregation of segments, chart types and structure.
4.1 Design Concept
The underlying concept was based on three levels of detail. At
the lowest level were the charts that presented each attribute in
the patient histories. At an intermediate level, those charts were
integrated into a dashboard that showed all of the attributes for
either the whole history of patients (see Figure 1) or a given
segment/cohort of patient histories (see Section 3.3). For this
intermediate level we use the term static dashboard because users
could not interact to change the charts, unlike the dashboards
that are commonly used in business intelligence applications. At
the highest level, the static dashboards were displayed as small
multiples in a dashboard network to show each segment in the
histories of a patient cohort (see Figures 3 and 4).
Each static dashboard was self-contained, meaning that it
summarized a particular state in the patient histories by showing
the attribute values. This meant that users could compare any two
temporal segments of the patients’ histories by looking at the
corresponding static dashboards. An alternative approach would
10485
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Fig. 1. Patient segment visualization showing detailed information about
10,485 patient segments at a glance. In this example the visualization
provides an overview of all patient history segments of the dataset.
Depending on the available display space the visualization shows ex-
planatory labels for every encoded attribute. Analysts can assess the
distribution of values in detail including label information. In addition,
an enlarged visualization (referred to as a view [46]) helps to lookup
attribute information for smaller visualizations and thus can serve as a
legend in a multiple-views application.
have been for each static dashboard to show the changes in the
attributes since the previous static dashboard, but that would have
made it more difficult for users to compare segments that were
either not adjacent in a dashboard network or that are related to
different cohorts.
Making the dashboards static meant that users would be able
to make observations with the glance of an eye, instead having to
interact and rely on their memory of previous views of the data.
Static dashboards may also be printed out and are well-suited for
use in meetings (e.g., to review the quality of care and patient
outcomes in a treatment unit).
4.2 Iterative Design Process
The static dashboard design went through nine main iterations (see
Figure 2), during which we interviewed medical experts, tested
design alternatives, and held critical discussions with visualization
experts. The data attributes that were encoded in the final iteration
are described in Table 1, and a summary of the iterations is as
follows.
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Fig. 2. Evolution of the visualization design. Basically, nine core iterations mark the design process each posing an improved result. Interviews,
observations, discourse, and informal tests helped to gain valuable feedback in the course of the process. In summary, crucial factors for improving
the visualization were orderedness, attribute grouping, separation, symmetry, and a selective use of color.
v1 showed four treatment variables (OP, RTX, HT & CHT) and
an outcome variable (resistance to hormone therapy; HR) as pie
charts, the pT-status, the pN-status and the sum of Gleason scores
as colored bar charts, the number of patients who had undergone
from one to four treatments (NB: these are labeled as primary,
secondary, etc. in v4 and v5) as a grayscale bar chart, and the
PSA values and changes as box plots and using a speedometer
metaphor, respectively. In retrospect, this first design was rather
rudimentary.
v2 added a circular border to separate each static dashboard
within a dashboard network, and included the Gleason scores
as a heat map. Other charts were moved to improve the static
dashboard’s structure (for details, see Section 4.6).
v3 condensed all of the treatment variables into a single
pie chart, and the number of treatments into another pie chart.
However, that was not successful because it meant that the pie
chart showed the relative frequency of each treatment rather than
the proportion of a cohort who had had each treatment (or number
of treatments, in the case of the second pie chart). This iteration
also separated the pre- and post-surgery attributes by a vertical
line for the first time.
v4 involved three substantial changes. First, the border was
changed to an octagon because that allowed the dashboard net-
works to be more compact and, in our opinion, is more aesthetic
than a square border. Second, the pie charts were changed so
that the radius of the shaded part of each segment showed the
proportion of a cohort who had each had a given number of
treatments. Third, the design of the PSA charts was changed after
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user tests indicated that the speedometer was not intuitive. The
new design used box plots to show the distribution of the PSA
values pre-operatively, the PSA values at the start and end of the
segment, and the PSA trend during the segment (up or down). The
new design met with the approval of the medical experts.
v5 also involved three changes. Redundant coloring was re-
moved from the bar charts, the Gleason score heat map was
changed to use size encoding to further reduce the use of color, but
color was added to the octagonal border to show the distribution
of patient well-being scores [11]. The latter change was rejected
after informal user feedback indicated that the scores were difficult
to understand and the users reported “restlessness” in a border
element that should be a simple outline.
v6 replaced data about the number of treatments with outcome
variables (OK, BCR, HR, Meta and DOD), complementing the
treatment variables This enabled the experts to conduct cause-
and-effect analyses with the dashboard networks for the first time.
v7 was used to investigate the usage of bar charts to depict
outcome variables. However, users tried to identify relations be-
tween the three bar charts, instead of relating outcome variables
with treatment variables, so that design change was dropped.
v8 involved three substantial changes. The first was to revert
back to showing one attribute in each pie chart, providing simple
charts that should be understandable by most users. The second
was to position the treatment and outcome variable pie charts so
that they were in order of increasing severity. The third was to
add pie charts for two treatment-related attributes (pRTX: end of
radiation, HR: hormone refractory), but feedback from the medical
experts indicated that the additions were not welcome.
v9 added lines to divide the static dashboard into regions that
each contained the chart(s) for a set of attributes, which was
explicitly welcomed by some participants in the user evaluation.
The design was also given some final polishing, such as the
optimization of label sizes.
4.3 The Use of Color
Color is used to discriminate the four treatment variables, and
the four outcome variables. To some degree, this use of color
is redundant since the variables can be distinguished by their
different positions in a static dashboard. However, interviews with
visualization experts suggested that coloring should be included in
the approach for three reasons:
• The lookup of colored pies is pre-attentively perceivable
• Color eases visual comparison for small visualizations
• The colors have a semantic meaning
The colors were chosen with input from the medical experts
about color semantics of the domain. However, we did equalize
the brightness and saturation of the colors, following input from
an expert in perception and cognition. The four outcome variables
follow the idea of a traffic light metaphor (plus black for DOD),
according to the severity of the disease. A consequence of the
metaphor and the domain-specific colors was that both Meta and
CHT used a reddish color, but as both are severe conditions the
semantic overlap was considered acceptable. Overall, the colors
seemed to be correctly interpreted by participants in the user
evaluation. However, the colors are not colorblind safe, which is a
possible subject for future work. One option is to display the four
biological conditions in different brightnesses of a given hue, with
a second hue used for the four therapy states, and a second option
is to use a grayscale scheme because the labels (OP, RTX, etc.)
allow each chart to be identified.
In addition to using color for the treatment and outcome
variables, we used a gray to dark red colormap to emphasize the
severity of Gleason scores, which increases from the lower left to
the upper right of the 2D grid. This color encoding supports the
visual comparison of Gleason scores.
4.4 Visual Aggregation of Segments
One challenge in the design was showing multivariate information
for multiple segments in a single dashboard. The number of
segments visualized with a single static dashboard depends on the
aggregation strategy applied to assign segments to groups (see
Section 3.3.3). For the user evaluation in the present research
the number of segments in a group ranged from eight (the right
hand static dashboard in Figure 3 to 10,485 (see Figure 1). We
addressed the challenge by choosing types of charts that are
capable of showing either a portion of items (the pie charts) or
a distribution of values (the other charts). Details are provided in
the next section.
4.5 Chart Types
A key challenge that we faced was to design a static dashboard
that showed many attributes of patients’ histories, and a strength
of the final design (v9) was its use of four different chart types
(pie charts, bar charts, box plots and a heat map), which helped
the groups of attributes to stand out from each other. This section
reflects on those choices of chart.
Box plots were used for the PSA values because they provide
a compact way of presenting distributions of numerical values and
are widely used in the medical domain. The box plots were also
more intuitive than the novel speedometer metaphor that was used
in v1–v3.
The pT-status and pN-status are both ordinal data, and this re-
quired a chart that could show either the number or the proportion
of patients. We used a bar chart, which is the obvious choice. It
would have been possible to use a pie chart, but for the pT-status
that would have broken the guideline that there should be no more
than six segments [47], and the symmetry of the static dashboard
was increased by using the same chart type for both the pT-status
and the pN-status.
The Gleason score is also ordinal but has two dimensions.
These could be shown together with a grid-based encoding,
which was provided by a heat map. However, during the design
iterations we decided that it was better to encode the frequency of
each combination of Gleason scores using size rather than color,
because that allowed the most common combinations to stand out
while reducing the need for color.
The most challenging attributes were the treatment and out-
come variables. We used pie charts rather than bar charts because:
(a) we wanted those variables to stand out from the other groups
of variables (bar charts were the preferred option for the pT-
status and pN-status), and (b) we consider pies to be more
appropriate for showing small proportions that should stand out
due to their domain importance (e.g., Meta, DOD, and CHT).
After investigating three designs of pie chart (see v1, v3, and v4),
we chose a design that showed one attribute in each pie chart,
trading-off the simplicity of each chart with the number of charts
that were required.
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Fig. 3. The history of a cohort of patients who all had a pT-status of pt4. From left to right the static dashboards are ordered by the number of
treatments that the patients received (1-4). Two different signatures of treatments exist in the second segment (OP-RTX and OP-HT). Twenty-nine
patients have a third segment and eight have a fourth, showing that this cohort contains patients who have the most severe treatment (CHT) and
get metastases (Meta) and die (DOD). The colors are the same as shown in Figure 1.
4.6 Structure
The final design (v9) structured the data by applying principles for
ordering, grouping, separation, and symmetry. Ordering worked
in three ways. The first was for data that was guaranteed to be
gathered in a particular order, which was presented in temporal
order from left (earliest) to right (latest). An example is the three
PSA measurements that were gathered pre-operatively, and at the
start and end of each segment. The second was to position the
treatment variables in order of severity (OP, RTX, HT, and CHT),
as defined by medical experts (see v8 and v9). The third was to
apply a data-driven approach and calculate the order from the
sequence in which events typically happened, with an example
being the four outcome variables (see v8 and v9).
Grouping took advantage of the hierarchical nature of the
attributes, and was applied to some extent in all nine iterations to
the PSA measurements, and the treatment and outcome variables.
However, driven by user feedback, the grouping became more
explicit as the designs progressed by adding lines to separate the
groups – v1, v4 and v5 relied solely on space to separate the groups,
whereas v9 was the only design that used lines to separate each
group from its neighbors.
Symmetry concerned the way in which the attribute groups
were arranged within the visualization as a whole, and depended
on the fact that there were similarities between some of the
attribute groups. Symmetry was achieved by balancing the types
of chart that were used on opposite sides of either an horizontal or
vertical axis, and is most evident in v2-6 and v9.
5 USAGE SCENARIO
This section outlines three usage scenarios for the static dash-
boards, in line with the groups of required functionalities in
Section 3.2. The first scenario (Section 5.1) shows how a single
static dashboard may provide an overview of the entire set of
segments of the dataset that was described in Section 3.3. The
second scenario (Section 5.2) shows how users may identify
temporal characteristics of a specific patient cohort. For that, we
decided to group the dashboard network by the treatment signature
but, of course, other groupings are possible, e.g., with respect to
outcome variables. The third scenario (Section 5.3) depicts how
dashboard networks can be used for the visual comparison of the
histories of two patient cohorts.
5.1 Overview of the Entire Dataset
Overall, the segmentation algorithm described in Section 3.3
created 10,485 segments for the 2,000 patients in the dataset.
Despite the amount of aggregation that was needed to reduce all of
those segments to information that could be displayed in a single
static dashboard (see Figure 1), the visualization preserved the
detail that users needed to make a number of observations.
The information for static attributes on the left of the dash-
board shows that pt2c, pt3a, and pt3b are the most often occurring
pT-status values, and the most often observed Gleason scores
are 3+4 and 4+3. The pN-status N0 is observed in over 6,000
segments. At the upper right the visualization shows roughly one
quarter of the patient segments were in a state of OK, while
about three quarters of the segments indicate BCR. The portion
of patients suffering from metastases (Meta) remains fairly small,
which particularly applies to the number of patients that died
(DOD). According to the dataset, 100% of the patients had OP,
about two thirds of all cases had radiation treatment (RTX), about
one quarter received hormone treatment (HT), and only a small
portion of patients had chemotherapy (CHT).
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Fig. 4. The history of a cohort of patients who all had a pT-status of pt2c. From left to right the static dashboards are ordered by the number
of treatments that the patients received (1-3). Two different signatures of treatments exist in the second segment (OP-RTX and OP-HT). Over
nine hundred patients started with segment one and over two hundred have a third segment. However, this cohort contains only few cases with
metastases (Meta), virtually no deaths (DOD) and none of the patients received chemotherapy (CHT). The colors are the same as in Figure 1.
5.2 Identify Longitudinal Changes
Figure 3 shows an example dashboard network with five static
dashboards that are ordered by the number of treatments that
a patient had received (the treatment stage; left to right) and
the combination of treatments (the treatment signature; top to
bottom). The dashboard network in Figure 3 depicts the history
of the cohort of patients who all had a pT-status of pt4. Users can
make observations about longitudinal changes by comparing the
dashboards in the network.
In the first stage (left) the only treatment that patients had
received is OP. The ratio of patients with status OK is considerably
higher than in Figure 1.By contrast, the outcome variable BCR is
lower than the overall distribution shown in Figure 1. Moreover,
a strong increase in the PSA value can be observed. In the second
stage, two different treatment signatures exist (OP & RTX and OP
& HT): patients with RTX had lower PSA values, but the PSA
value increased after the treatment in many cases. For patients
receiving HT, the situation is somewhat opposite, with higher but
slightly decreasing PSA values. HT seems to have been prescribed
for patients with more severe biological situations, where in some
cases the first Meta are diagnosed. Other indicators for the more
hazardous biological state of HT are the pN-status, which contains
more N1, and the Gleason score 5+4. Finally, 100% of the patients
receiving RTX have a BCR, hinting at the usual treatment of a
biochemical recurrence with radiation therapy. If patients reached
the third and fourth stage, the biological condition had become
more severe. Many patients had diagnoses of Meta and some died
DOD. The PSA values were high and literally shot through the
roof in stage four. Chemotherapy was given only in stage four, as
a last resort.
5.3 Comparison of two Cohorts of Patients
The dashboard network described in Section 5.2 also allows the
comparison between cohorts that are displayed in separate sets of
visualizations. The following usage scenario uses Figures 3 and 4
to depict two cohorts with a different pT-status (pt4 and pt2c).
One of the most obvious differences between the cohorts is
the missing fourth stage in Figure 4, indicating that pT-status pt2c
does not lead to CHT. In stage one both treatment signatures share
OP as the first form of treatment, which is pre-defined in the
dataset. A closer look at the PSA trend reveals that the PSA value
of the pt4 cohort increases considerably stronger in the first stage.
In stage two, the treatments received by the pt2c cohort have less
implications on the PSA value progression. One hypothesis may
be that low PSA values are less responsive to treatments. These
observations indicate that pT-status pt2c has a better prognosis
than pt4, which is a hypothesis that can be validated as follows. In
stage three only a few pt2c patients had Meta and few patients
died. Similarly, the ratio of the extraprostatic extension of the
prostate cancer (N1) is substantially higher for pt4, while N0
dominates for pt2c. The PSA value remains at a low level in stage
three for most patients in pt2c, particularly when compared with
pt4. The visual comparison of Gleason scores reveals a dominance
of less severe scores for pt2c (e.g., 3+4) when compared with
the pt4 cohort (4+3, 4+5). The overall visual comparison of the
two cohorts indicates that pt2c is a considerably more pleasant
diagnosis than pt4.
6 USER EVALUATION
We present the results of a user evaluation to assess the usefulness
of the dashboard networks, using three different user groups: non-
experts, visualization experts, and medical experts. These groups
span the intended audience for our dashboard networks. Medi-
cal experts could benefit from visualization to help understand
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Fig. 5. The number of observations made in T1 by the three user
groups. The standard error (SE) is depicted with error bars. Non-experts
identified about 13 of all observations, medical experts about 18.
variations in patient histories over time and between cohorts.
The general public are becoming ever more involved in decision-
making about their own treatment, which should be made easier
by appropriately designed visualizations, and the same is true
for public-patient involvement in health research. Visualization
experts lie in-between the other two groups, with the medical
knowledge of the general public but with specialist knowledge
about the pitfalls and advantages of different styles of visualization
and encoding.
6.1 Method
6.1.1 Participants
We recruited 14 participants (2 female, 12 male). All participants
had normal vision and did not report color blindness. Their age
ranged from 22 to 51 (Median = 32, SD = 8.01). Each participant
had at least a diploma/master’s degree, five had a PhD degree or
higher. Five participants were classified as non-experts because
their background was neither in visualization nor prostate cancer.
Five participants worked in information visualization research
or application, but not in prostate cancer, and are referred to
as visualization experts. The remaining four participants were
prostate cancer clinicians and are referred to as medical experts.
6.1.2 Procedure
The evaluation took place in a quiet room that contained a
participant and always the same interviewer. The evaluation was
divided into three parts: introduction (approximately 10 min),
familiarization (10 min), and tasks (20 min).
The introduction started with an explanation of a background
to prostate cancer (if necessary) and the 15 attributes encoded in
the visualization. Then the current state of the art was outlined
as described in the introduction section of this paper, and our
approach (the visualization of multiple attributes of multiple
patient histories) was explained. We showed example images of
the dashboard networks to introduce the design and the prostate
cancer data in combination with visualization.
The familiarization phase included two questions to ensure
that participants understood the data and the static dashboards and
networks. First, we used Figure 1 to provide an overview of all
segments of the data and to give an impression of the overall
distribution of the patient histories (see Section 5.1 for details).
The second question was whether or not participants were able to
identify the treatment sequences depicted in Figure 3.
In the main part of the evaluation, the participants were asked
to conduct two tasks using screenshots (see Figures 1, 3, and 4).
We explained that Figure 1 could be used as a legend for the static
dashboard and a summary of the data segments provided with
the dataset. When performing the tasks, communication with the
non-expert vis-expert domain-expert 
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Fig. 6. The number of observations made in T2 by the three user groups.
Error bars show the SE. The analytical task is substantially different from
T1, but the pattern between the groups is similar.
participant was kept at a minimum, so only general questions of
understanding were answered. The tasks were:
• T1 Identification of characteristics of a patient cohort
• T2 Visual comparison of two patient cohorts
In T1 the participant was asked to identify the characteristics
and longitudinal changes of a single patient cohort that had a
pT-status pt4 (see Section 5.2 for details). The participant was
provided with a static dashboard showing an overview of all of
the patients (see Figure 1) and a dashboard network showing the
pt4 cohort (see Figure 3). The treatment signature of the cohort
was shown in four stages from a single treatment (always OP)
on the left up to stage four (four treatments) on the right. At
the second stage two different treatment signatures exist and are
shown above the other. Some patients received OP and RTX, while
other patients received OP and HT.
In T2 the participant was asked to identify differences between
the characteristics of the two patient cohorts (see Section 5.3).
The two cohorts had a pT-status pt4 and pt2c, respectively, and
the participant was provided with Figure 1 (overview), Figure 3
(pt4 cohort) and Figure 4 (pt2 cohort). Again, the history of each
cohort was presented so that the number of treatments increased
from left to right.
6.2 Results
In each task, the participants were asked to describe the character-
istics of given patient cohorts, which we refer to as observations
[48]. If participants made similar observations then they were
merged.
The first question in the familiarization phase concerned the
overview of all of the patients that is depicted in Figure 1. A table
in the supplemental materials provides lists the 12 observations
that were made by the participants. The second question was
whether or not participants were able to identify the treatment
sequences depicted in Figure 3. All 14 participants were able to
describe that every patient in the cohort started with OP in the
first stage, followed by a second treatment in stage two (OP-
RTX or OP-HT). In the third stage the participants had hardly
any problems in identifying that OP, RTX, and HT were taken,
combining the treatment orders OP-RTX-HT, as well as OP-
HT-RTX. Finally, all participants noticed that CHT was always
conducted last.
The remainder of this section reports the results for T1 and
T2, and is divided into three sections. Information about all of
the observations that participants made in those tasks is provided
in tables in the supplemental materials. First we compare the
observations that were made by the three groups of participants.
Then we analyze the complexity of the observations, and followed
this by analyzing the data attributes that were used. Together, these
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Fig. 7. Fine-grained analysis of observation complexities for T1 and
T2. Colored cells in the grid depict the number of observations the
participants had, corresponding with the attribute count, attribute type,
and the number of static dashboards (segments) that were used.
results show how each component (chart) of the static dashboards
were used, and the extent to which participants were able to
integrate many different components from the dashboard networks
to make the observations.
6.2.1 Between-groups Comparisons
In T1 the number of participants who made each observation
was significantly correlated for all three pairs of user groups:
non-experts vs. visualization experts (r(31) = 0.63, p < .01),
non-experts vs. medical experts (r(31) = 0.52, p < .01) and
visualization experts vs. medical experts (r(31) = 0.64, p < .01).
However, medical experts made more observations (see Figure 5)
and showed greater consistency. Thirteen observations were made
by all of the medical experts, but only three observations were
made by all of the visualization experts and two observations
by all of the non-experts. One striking difference was that the
medical experts focused more on treatments, with five of the
treatments observations being made by all of the medical experts.
No treatment observation was made by all members of either
the non-experts or visualization experts group. This may be an
indication that the mental models of medical experts are targeted
towards the treatment of patients, while the other two groups
focused on more general observations.
There was a similar pattern of results for T2. The number
of participants who made each observation was significantly
correlated for all three pairs of user groups: non-experts vs.
visualization experts (r(24) = 0.73, p < 0.01), non-experts vs.
medical experts (r(24) = 0.46, p < 0.05) and visualization experts
vs. medical experts (r(24) = 0.58, p < 0.01). Medical experts made
more observations (see Figure 6) and showed greater consistency,
with 15 observations made by all of the medical experts, but only
seven observations were made by all of the visualization experts
and five observations by all of the non-experts. Three of the
treatment observations were made by all of the medical experts,
but no treatment observation was made by all members of either
the non-experts or visualization experts group.
6.2.2 Complexity of the Observations
Two ways of quantifying the complexity of each observation are
the number of attributes and the number of static dashboards that
were involved. There was little difference between the three user
groups for either complexity measure, so this section combines
the observations for all of the participants.
The number of attributes that were involved in each obser-
vation ranged from 1–4, the number of static dashboards ranged
from 1–9 and, as expected, the former tended to decrease as the
latter increased (see Figure 7). The overall complexity of each
observation was calculated by multiplying the number of attributes
and the number of static dashboards. This overall complexity was
in the range 2–27, with the observations generally more complex
in T2 than T1 because the former involved two cohorts rather than
one (9 vs. 5 static dashboards).
The complexity data demonstrates the flexibility of our dash-
board networks. Each static dashboard contained 12 charts, mean-
ing that, at the glance of an eye, participants chose flexibly from a
total of 60 (T1) or 108 different charts (T2) to make a wide variety
of observations about longitudinal changes within and differences
between patient cohorts.
6.2.3 Attributes
The multitude of attributes included in the static dashboards raises
questions about whether all visual encodings of the attributes were
useful and participants preferred some attributes over others. To
investigate this, we mapped each observation to its attributes.
The mapping for T1 is presented in Figure 8. Fourteen at-
tributes are involved, and the most popular attributes are PSA
Trend (PSA T.), RTX, HT, and CHT. The focus of medical experts
on treatments is clearly shown. By contrast, outcome variables
(PSA Trend, PSA Value, Meta, and DOD) were identified by all
three groups almost equally. This may be due to the fact that non-
experts and visualization experts focused on the well-being status
of patients rather than patient treatment.
The mapping for T2 (comparing two patient cohorts) is pre-
sented in Figure 9 and shows a different distribution of observa-
tions. Overall eleven attributes were taken into consideration. The
most common attributes are pN-status (pN-St.), PSA Value (PSA
V.), and PSA Trend (PSA T.). At least two reasons may have an
influence on the resulting distribution. First, the comparison task
emphasizes attributes showing differences between the pt4 and the
pt2c cohort, and Figures 3 and 4 clearly reveal major differences
between the Gleason score, PSA values and trends, and the pN-
status. The second reason may be that the usage scenario of T2 is
based on treatments that were received. The treatment signatures
of the two cohorts were similar, although the pt2c cohort had to
undergo fewer treatments and no CHT at all.
6.3 Data Quality Observations
Using the dashboard networks, participants identified two data
quality problems with the PSA attributes. These problems show
how our dashboard networks may be used to verify the quality
and integrity of data.
First, some of the medical experts queried the pre-OP PSA
because the value was rather unexpected (the last PSA value before
OP has an influence on patients’ development in the follow-up
phase). On investigation, we found that the data model contained
an error, meaning that pre-OP PSA was incorrectly shown to be
constant across the dashboard network.
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Fig. 8. The mean number of times participants made an observation that was about each attribute in T1 (characteristics of the patient cohort).
Error bars show the SE. Abbreviation: PSA PRE is pre-OP PSA. Medical experts emphasized treatment attributes while outcome variables were
identified equally. Overall, RTX and HT were most interesting to solve T1.
The second problem concerned some unexpected zero values
of the PSA values for the pt2c cohort (see Figure 4), which in
two of the static dashboards caused the whiskers of the boxplot to
spread down to 0.0. Two visualization experts identified this issue,
leading to discussions about the way the value domain should be
represented.
6.4 Discussion
The overall success of the design is demonstrated by the fact that
all three groups of participants (non-expert, visualization experts
and medical experts) made a sizable number of observations in
each task, with medical experts making the most. At the glance
of an eye, participants were able to pick and mix information
from 2 – 27 charts out of a much larger number of charts in the
dashboard networks (60 and 108 charts in T1 and T2, respectively)
to make each observation. Every single attribute was used in
some observations and, of course, the frequency with which each
attribute was used was affected by the application domain.
The evaluation had a number of limitations. The most impor-
tant one was that the data was more orderly and constrained than in
electronic health records (EHRs) as a whole, because there were
only a small number of treatments and outcomes (four of each,
compared with tens of thousands of codes in disease classifications
such as ICD-10) and the data was curated so its quality was higher
than is often found in EHRs. Other limitations were the use of
a fairly small number of participants, and the fact that all of the
participants were familiarized with the dashboard networks at the
beginning of the evaluation. In a real-world setting, typically it
would not be possible to spend time familiarizing non-experts
(e.g., patients) prior to a doctor/patient consultation.
Although the design was specific to a particular medical do-
main, there are aspects that provide guidance for the application of
the design to other domains. Some of that guidance results in three
design principles that help to provide structure for static dash-
boards: (1) divide charts into groups according to their attributes,
(2) position the charts so that they are ordered according to time,
and (3) explicitly separate each group of charts. A fourth principle
is to arrange charts symmetrically, where possible, because the
improved aesthetics [49] is likely to make it easier for users to
compare static dashboards longitudinally or between-cohorts.
Encoding multiple attributes causes conflicts in the choice
of visual channels, so we considered several design alternatives
for each attribute encoding. One example can be seen in design
v7 (Figure 2) where the outcome variables are encoded with a
barchart instead of a pie chart. As a result, the symmetry between
outcome variables (top) and treatments (bottom) was lost and users
started to seek connections between the outcome variables (right)
and the pT-status (left), which was not intended. Another example
is the limited use of color, which allowed more flexibility for
dealing with semantic overlap between the meaning of different
attributes (e.g., Meta and CHT both indicate severe patient condi-
tions and hence the use of a reddish color). In this regard, we refer
to a quote from David Travis ”When correctly used, the benefits
of color are unrivaled ... However, when incorrectly used, color
has the potential to make a system unusable“ [50].
The design also had some limitations, which we briefly sum-
marize here. In the usage scenarios used for the evaluation, we
aggregated the data for patients who received the same treatment
at a given stage (e.g., stage 3 in Figure 3), but some participants
said that it may be useful to separate patients who had received
different sequences of treatments (e.g., OP-RTX-HT vs. OP-HT-
RTX). The design could be improved for attributes that remain
constant, so users do not have to compare static dashboards
to deduce that an attribute has not changed. The segmentation
process was designed to differentiate between changes in the
attributes, but some types of treatment (e.g., hormone therapy)
take place over an extended period of time. A color legend should
have been provided for users who were not familiar with the
chosen domain-specific norms. Informal feedback indicated that
the presentation of the PSA attributes could be improved but the
best solution remains an open question. It could be argued that
the PSA trend is redundant, because that is implicit from the PSA
start and PSA end boxplots. However, many participants expressed
observations in terms of the trend, rather than absolute PSA values,
and one participant suggested that the trend should be discretized
to three directions (constant, up, and down) which would allow
the current trend arrow to be made more salient.
Finally, the scalability of the design to more diverse patient
cohorts remains an open question. As more treatment pathways
are introduced (e.g., imagine four treatments that could occur in
any order, rather than the two orders of the present research) the
complexity of the dashboard networks will increase. This will
increase the cognitive effort of making comparisons and at some
point, as with all visualizations, the design will break down.
7 CONCLUSION
This paper describes a design study that developed a novel method
for visualizing patients’ medical histories so that longitudinal
and cross-cohort patterns could be understood. Our solution pre-
sented those histories using a three-tier visualization structure
that comprises: (1) charts that presented each attribute in the
patient histories, (2) static dashboards that contained the charts
for given temporal segments of the histories, and (3) a dashboard
network that showed all of the segments for a given patient cohort.
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Fig. 9. The mean number of times participants made an observation that was about each attribute in T2 (comparison of two patient cohorts).
Participants in all three groups emphasized biological attributes and early indicators for the disease to answer T2. Error bars show the SE.
Central to the dashboard network is our data segmentation method,
which preserves the order in which events occur, rather than the
events’ actual time. This allows the static dashboards to reveal the
proportion of a population (e.g., patients) with each attribute, and
the dashboard network to show longitudinal and between-cohort
patterns.
The dashboard network design evolved during nine iterations,
during which we interviewed medical experts, tested design alter-
natives, and held critical discussions with visualization experts.
The success of the design is shown by the large number of
observations that were made by users who ranged from non-
experts to medical experts, and the diversity of those observations
in terms of both the number of attributes and the number of history
segments that were involved.
There are a number of future avenues for our research. One
is to investigate the ability of dashboard networks to handle
missing or noisy data. A second one is to understand the extent to
which the networks scale in terms of the number of attributes,
static dashboards and dashboard networks that are possible to
be displayed while still allowing users to easily make diverse
observations. Finally, the effectiveness of dashboard networks
should be investigated in other application domains.
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